ATP Binding Cassette Transporter A1 (ABCA1) Antibody

Este producto es parte de ABCA1 - ATP Binding Cassette Transporter A1
Product Graph
273€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
ATP Binding Cassette Transporter A1 (ABCA1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx103801
tested applications
WB, IHC, IF/ICC

Description

Polyclonal Antibody to ATP Binding Cassette Transporter A1 (ABCA1).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
ATP Binding Cassette Transporter A1 (ABCA1)
Host
Rabbit
Reactivity
Mouse
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P41233
Alias
TGD,ABC1,CERP,ABC-1,HDLDT1,HPALP1,HDLCQTL13
Background
Antibody anti-ABCA1
Status
RUO

Descripción

ABCA1 is a transmembrane protein belonging to the ATP-binding cassette (ABC) transporter family, playing a vital role in lipid metabolism and cellular cholesterol efflux. It facilitates the transport of cholesterol and phospholipids from cells to apolipoproteins, such as ApoA-I, in the plasma, which is a critical step in the formation of high-density lipoprotein (HDL). Structurally, ABCA1 consists of two transmembrane domains and two ATP-binding domains that utilize ATP hydrolysis to drive lipid transport. It is highly expressed in macrophages, hepatocytes, and other cells involved in lipid metabolism. The activity of ABCA1 is essential for maintaining cellular cholesterol homeostasis and preventing lipid accumulation, particularly in macrophages, where its dysfunction can lead to foam cell formation and atherosclerosis. Mutations in the ABCA1 gene are associated with Tangier disease, a rare disorder characterized by very low HDL levels and increased susceptibility to cardiovascular disease. As a key regulator of cholesterol efflux and HDL biogenesis, ABCA1 is a therapeutic target for managing dyslipidemia and cardiovascular risk.

Related Products

EH1420

Human ABCA1 (ATP-binding cassette sub-family A member 1) ELISA Kit

Ver Producto
ER1451

Rat ABCA1 (ATP Binding Cassette Transporter A1) ELISA Kit

Ver Producto
QT-EH1420

Human ABCA1 (ATP-binding cassette sub-family A member 1) QuickTest ELISA Kit

Ver Producto